Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
27
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
3D Systems
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Margin Risks And Tariffs Will Dampen Healthcare But Yield Recovery
Key Takeaways Growth prospects in healthcare and critical markets are challenged by macroeconomic, trade, and adoption-related uncertainties among key customers. Innovation and restructuring efforts may be undermined by competition and execution risks, threatening profitability and long-term revenue stability.
View narrative
US$2.50
FV
16.0% undervalued
intrinsic discount
-4.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Alpha Teknova
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Funding Gaps Will Hamper Biopharma Yet Resilience Will Emerge
Key Takeaways Dependence on a limited product portfolio and slow new offerings may restrict growth amid challenges from industry consolidation and price competition. Margin improvements from process automation face risks from regulatory complexity, compliance costs, and supply chain shifts, threatening long-term profitability.
View narrative
US$8.00
FV
40.6% undervalued
intrinsic discount
14.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Verano Holdings
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Cannabis Competition And Credit Risk Will Erode Margins Yet Stabilize
Key Takeaways Regulatory shifts could expand markets but also intensify competition, leading to price pressure and margin challenges for Verano. Limited banking access and persistent regulatory burdens restrict capital, valuation growth, and sustainable long-term earnings despite operational and branding gains.
View narrative
CA$2.76
FV
22.7% undervalued
intrinsic discount
1.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Service Properties Trust
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Remote Work, Alternative Lodging And High Debt Will Undermine Profitability
Key Takeaways Shifts in work trends and alternative lodging are weakening hotel demand, eroding pricing power, and exposing persistent revenue challenges. High tenant concentration and debt burdens heighten earnings volatility and limit financial flexibility amid rising costs and refinancing hurdles.
View narrative
US$2.00
FV
40.0% overvalued
intrinsic discount
-8.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Agora
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Regulatory Risks Will Stall AI Market Progress Yet Hope Lingers
Key Takeaways Expansion in AI-powered engagement and developer ecosystem boosts long-term potential, but uncertain adoption and rapid commoditization threaten sustained revenue and margin growth. Geographic concentration and evolving regulatory risks, especially in China, increase compliance costs and create obstacles to stable international market expansion.
View narrative
US$5.00
FV
29.4% undervalued
intrinsic discount
9.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Quanterix
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Life Sciences Challenges Will Limit Prospects But Synergies Will Aid
Key Takeaways Growth opportunities from expanded technology and strategic partnerships are balanced by ongoing risks from high R&D spending, regulatory pressures, and integration challenges. Intensifying competition, healthcare budget constraints, and potential for technology commoditization threaten sustained revenue and margin improvement despite strong market fundamentals.
View narrative
US$5.00
FV
3.4% undervalued
intrinsic discount
20.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Hudson Pacific Properties
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Oversupply And Tech Risks Will Drag Down West Coast Offices
Key Takeaways Reliance on tech-focused West Coast markets and ongoing demographic shifts expose the company to heightened vacancy and leasing risks. Elevated vacancy rates, market oversupply, and regulatory compliance costs continue to compress margins and delay earnings recovery.
View narrative
US$2.00
FV
34.5% overvalued
intrinsic discount
4.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Arteris
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Trade Tensions And Risks Will Limit Markets Yet Yield Hope
Key Takeaways Revenue growth and market share are threatened by geopolitical shifts, industry consolidation, and increased international competition as countries localize semiconductor IP development. High dependency on key clients, rising R&D expenses, and pressures from open-source standards could limit pricing power, margin expansion, and long-term earnings stability.
View narrative
US$11.00
FV
9.4% undervalued
intrinsic discount
18.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
GrafTech International
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Stricter Emission Standards Will Erode Profitability And Market Share
Key Takeaways Structural shifts toward greener steelmaking and alternative technologies threaten the core demand for graphite electrodes, undermining GrafTech's long-term growth prospects. Heightened regulations, customer concentration, and increased global competition pose risks to profitability, cost management, and revenue stability.
View narrative
US$0.80
FV
21.3% overvalued
intrinsic discount
28.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies